首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Medical oncology

缩写:MED ONCOL

ISSN:1357-0560

e-ISSN:1559-131X

IF/分区:4.7/Q2

文章目录 更多期刊信息

共收录本刊相关文章索引5087
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Xueyi Qin,Guichen Huang,Ying Han et al. Xueyi Qin et al.
Colorectal cancer (CRC) is a malignancy with high mortality. Due to the suppressive state of the tumor immune microenvironment (TIME), approximately 95% of microsatellite-stable (MSS) or proficient mismatch repair (pMMR) cases exhibit poor ...
Khadija Fatima,Iqra Fatima Khan,Sidra Fatima Khan et al. Khadija Fatima et al.
Hydroxyapatite nanoparticles (HANPs) have emerged as versatile and biocompatible platforms in cancer nanomedicine, offering multifunctional roles in drug delivery, imaging, and combinatorial therapy. Their structural similarity to bone apat...
Fang Zhou,Yi Zhang,JiaHeng Guan et al. Fang Zhou et al.
Interferon-induced transmembrane protein 3 (IFITM3) is overexpressed in acute myeloid leukemia (AML) and is associated with poor prognosis. Previous studies implicate IFITM3 in oncogenic processes and immune modulation; however, the mechani...
Shahad W Kattan,Amany I Almars,Ekramy M Elmorsy et al. Shahad W Kattan et al.
Colorectal cancer is one of the leading causes of cancer-related mortality worldwide, and its progression is strongly associated with oxidative stress, chronic inflammation, dysregulated apoptosis, and impaired autophagy. Although honokiol ...
Xiaochen Niu,Aijie Guo,Yifan Wang et al. Xiaochen Niu et al.
Glioma progression is heavily driven by heterogeneity and a highly immunosuppressive tumor microenvironment (TME). This study aimed to identify a robust long non-coding RNA (lncRNA) prognostic signature and elucidate its role in TME remodel...
Yiting Zheng,Chenran Xu,Tiefeng Zhu et al. Yiting Zheng et al.
This study investigates the antitumor effects and immunomodulatory mechanisms of Astragalus membranaceus (AM) injection at Zusanli (ST36) acupoint in a mouse model of lung cancer with chronic obstructive pulmonary disease (LC-COPD). Mice we...
Jinhu Ma,Ziyang Qiang,Wenhao Xie et al. Jinhu Ma et al.
Clear cell renal cell carcinoma poses unique challenges for immunotherapy, particularly with immune checkpoint inhibitors. Many ccRCC tumors exhibit an "immune-cold" tumor immunosuppressive microenvironment (TIME), characterized by poor T c...
Vikesh Kumar Shukla,Akshma Chauhan,Krishnajit Malakar et al. Vikesh Kumar Shukla et al.
Expedited regulatory approval pathways are vital for providing timely patient access to novel therapies in oncology and other serious conditions. The traditional drug development pathway can take significant time, substantial costs (often m...
Zhenlong Zhou,Haichun Zhou Zhenlong Zhou
Disulfidptosis is a novel form of programmed cell death. It is triggered by metabolic and redox imbalance. It is executed through the irreversible collapse of the actin cytoskeleton. Its core mechanism involves the 'SLC7A11-cystine-NADPH-ac...
Bing Li,Huilin Lu,Jiayi Huang et al. Bing Li et al.
The tumor microenvironment (TME) limits durable antitumor immunity by impairing CD8+ T cell responses. Memory like CD8+ T cells are important for long-term immune control but are often restricted in the TME. Dendritic cells (DCs) are key re...